Avior Wealth Management LLC Buys 3,270 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

Avior Wealth Management LLC grew its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 38.2% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 11,824 shares of the company’s stock after purchasing an additional 3,270 shares during the quarter. Avior Wealth Management LLC’s holdings in Prestige Consumer Healthcare were worth $1,017,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in PBH. Principal Financial Group Inc. raised its holdings in Prestige Consumer Healthcare by 3.2% in the 4th quarter. Principal Financial Group Inc. now owns 256,526 shares of the company’s stock worth $20,032,000 after purchasing an additional 7,890 shares in the last quarter. Sanctuary Advisors LLC raised its holdings in Prestige Consumer Healthcare by 5.4% in the 4th quarter. Sanctuary Advisors LLC now owns 18,175 shares of the company’s stock worth $1,425,000 after purchasing an additional 927 shares in the last quarter. Truist Financial Corp bought a new position in Prestige Consumer Healthcare in the 4th quarter worth $345,000. Kestra Investment Management LLC bought a new position in Prestige Consumer Healthcare in the 4th quarter worth $27,000. Finally, New York State Common Retirement Fund raised its holdings in Prestige Consumer Healthcare by 5.1% in the 4th quarter. New York State Common Retirement Fund now owns 16,098 shares of the company’s stock worth $1,257,000 after purchasing an additional 778 shares in the last quarter. 99.95% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several research analysts have commented on the stock. Royal Bank Of Canada upgraded shares of Prestige Consumer Healthcare to a “hold” rating in a report on Thursday, May 8th. Wall Street Zen upgraded shares of Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research note on Saturday, May 17th. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $93.33.

Prestige Consumer Healthcare Stock Down 0.3%

Shares of Prestige Consumer Healthcare stock opened at $83.37 on Friday. The company has a debt-to-equity ratio of 0.55, a current ratio of 4.20 and a quick ratio of 2.82. The company has a 50-day moving average of $83.93 and a 200 day moving average of $82.51. The firm has a market cap of $4.12 billion, a price-to-earnings ratio of 19.43, a PEG ratio of 2.50 and a beta of 0.45. Prestige Consumer Healthcare Inc. has a 1 year low of $64.94 and a 1 year high of $90.04.

Prestige Consumer Healthcare (NYSE:PBH) last issued its quarterly earnings results on Thursday, May 8th. The company reported $1.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.30 by $0.02. The company had revenue of $296.52 million during the quarter, compared to analyst estimates of $289.36 million. Prestige Consumer Healthcare had a net margin of 18.86% and a return on equity of 12.87%. Prestige Consumer Healthcare’s quarterly revenue was up 7.0% compared to the same quarter last year. During the same period last year, the business earned $1.02 EPS. As a group, sell-side analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current fiscal year.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.